Wolverine Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Wolverine Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-49,217	Closed	-$338K	–	2672
2014 Q1	$396K	Buy	49,217 +22,766	+86%	+$177K	0.01%	654
2013 Q4	$180K	Buy	26,451 +25,300	+2,198%	+$137K	﹤0.01%	1211
2013 Q3	$21K	Hold	1,151	–	–	﹤0.01%	2015
2013 Q2	$20K	Buy	+1,151	New	+$20.4K	﹤0.01%	2015

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Wolverine Asset Management's ARIA Position: Q2 2014 in Review

Wolverine Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2014, closing a stake of 49,217 shares — an estimated $338K sold.

Wolverine Asset Management first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $396K in Q1 2014. 169 funds tracked by Wall St. Rank hold ARIA as of Q2 2014.

Wolverine Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
Wolverine Asset Management sold 49,217 Ariad Pharmaceuticals Inc shares in Q2 2014, an estimated $338K.
Wolverine Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
Wolverine Asset Management's Ariad Pharmaceuticals Inc position peaked at $396K in Q1 2014.
169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2014.

Based on Wolverine Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.